Asemgul Kasenova

Asemgul Kasenova

Auto-generated profile, based on publicly available information

Asemgul Kasenova

Department of Neurology, NpJSC "Astana Medical University", Astana, Kazakhstan; Institute of Continuing Professional Education, NpJSC "Astana Medical University", Astana, Kazakhstan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Epilepsy Research
Verified
Journal Article
Open access
GKGaziz Kyrgyzbay
Gaziz Kyrgyzbay
DKDina Kalinina
Dina Kalinina
RARuslan Akhmedullin
Ruslan Akhmedullin
ZUZhassulan Utebekov
Zhassulan Utebekov
AKAsemgul Kasenova
Asemgul Kasenova
GZGuldana Zhumabayeva
Guldana Zhumabayeva
This study aimed to understand the prevalence of migraine in patients with functional seizures in general, as well as compared to patients with epileptic seizures. We conducted a literature search of the PubMed, Scopus, and Web of Science databases from database inception until July, 2024. We identified studies using an observational design and performed a meta-analysis to evaluate the association between migraines and functional seizures. We assessed the quality of the studies with the Newcastle-Ottawa Scale, and identified the pooled odds ratios (OR) and mean differences. Heterogeneity was investigated using the I² statistic, significance was determined using Cochran's test, and a post-hoc Begg's test was performed. This study was registered with PROSPERO (CRD42024558536). Of the 3248 studies identified, 13 studies (N = 2415) were eligible for inclusion. Out of 2415 patients with functional seizures, 763 (31.5 %) patients had comorbid migraine. The pooled OR for prevalence of migraine in individuals with functional seizures compared with those with epileptic seizures was 2.77 (95 % CI: 2.36-3.27), with a corresponding mean difference of 18 % ((95 % CI: 9 %-27 %). Quality assessment revealed moderate-to-high quality in all the included studies. This study revealed a high prevalence of migraine in patients with functional seizures. However, existing evidence is limited to a handful of observational studies. More studies are needed to evaluate the direction of the association and the clinical and therapeutic impact of migraine on functional seizures.

28 February 2023 in Наука и здравоохранение
Verified
Journal Article
Open access
SKShinalieva K.A.
Shinalieva K.A.
KAKasenova A.S.
Kasenova A.S.
ZMZhumabayev M.B.
Zhumabayev M.B.
AMAbdrakhmanova M.G.
Abdrakhmanova M.G.
BABekenova A.O.
Bekenova A.O.
MSMadirova S.E.
Madirova S.E.
Materials and methods. The study involved patients with clinically and laboratory proven type 2 diabetes mellitus. The cases group (Group 1) included patients with OSAS. The control group (Group 2) included patients without OSAS. Sleep duration and quality were assessed using respiratory monitoring. OSAS was screened using a portable night monitor. Cognitive assessment is performed using the Montreal Cognitive Test (MoCA). Three MoCA subscales were analyzed: visual-constructive function, executive function, and orienting function. Results. A total of 94 patients (58 women and 36 men, 61.7% vs 38.3%) took part in the study. The age ranged from 45 to 59 years. The MoCA subscales - visual-spatial and executive functions, Clock and Orientation, were lower in the main group compared to controls (p<0.05). In the control group, significant correlation between the MoCA indicator and BMI (r=0,39; p=0,015), waist circumference (r=0,48; p=0,002), neck circumference (positive) (r=0,33; p=0,040) and Hba1c (negative) was found. In the main group, 32.7% of participants had MoCA score below 26, in the control group - only 67.3% Conclusion. Lower sleep efficiency is associated with lower cognitive function in patients with abnormal glucose tolerance. Whether sleep optimization may improve cognitive function in these patients should be explored. Цель: изучить влияние синдрома обструктивного апноэ сна (СОАС) на когнитивные функции головного мозга у больных сахарным диабетом 2 типа. Материалы и методы: В исследование были включены пациенты с клинически и лабораторно подтвержденным сахарным диабетом 2 типа. В группу случаев (группа 1) вошли пациенты с СОАС. В контрольную группу (2-я группа) вошли пациенты без СОАС. Продолжительность и качество сна оценивали с помощью респираторного мониторинга. СОАС контролировали с помощью портативного ночного монитора. Когнитивное оценивание проводится с помощью Монреальского когнитивного теста (MoCA). Были проанализированы три подшкалы МоСА: зрительно-конструктивная функция, исполнительная функция и функция ориентировки. Результаты: Всего в исследовании приняли участие 94 пациента (58 женщин и 36 мужчин, 61,7% против 38,3%). Возраст колебался от 45 до 59 лет. Подшкалы МоСА - зрительно-пространственные и исполнительные функции, Часы и Ориентация - были ниже в основной группе по сравнению с контролем (р<0,05). В контрольной группе выявлена достоверная корреляция между показателем МоСА и ИМТ (r=0,39; p=0,015), окружностью талии (r=0,48; p=0,002), окружностью шеи (положительная) (r=0,33); p=0,040) и Hba1c (отрицательный). В основной группе 37,2% участников имели балл МоСА ниже 26, в контрольной группе - только 67,3%. Заключение. Более низкая эффективность сна связана с более низкой когнитивной функцией у пациентов с аномальной толерантностью к глюкозе. Следует изучить вопрос о том, может ли оптимизация сна улучшить когнитивные функции у этих пациентов. Зерттеу мақсаты: 2 типті қант диабетімен ауыратын науқастардың обструктивті ұйқы апноэ синдромының (ҰОАС) мидың когнитивті қызметіне әсерін зерттеу. Материалдар мен әдістер: зерттеуге клиникалық және зертханалық расталған2 типті қант диабеті бар науқастар енгізілді. Істер тобына (1-топ) ҰОАС бар науқастар кірді. Бақылау тобына (2-ші топ) ҰОАС жоқ пациенттер кірді. Ұйқының ұзақтығы мен сапасы респираторлық бақылау арқылы бағаланды. ҰОАС портативті түнгі монитормен басқарылды. Когнитивті бағалау Монреаль когнитивті тесті(MoCA) арқылы жүзеге асырылады. MoСa-ның үш ішкі шкаласы талданды: визуалды-конструктивті функция, атқарушы функция және бағдарлау функциясы. Нәтижелері және талқылауы: зерттеуге барлығы 94 пациент қатысты (58 әйел және 36 ер адам, 61,7% қарсы 38,3%). Жасы 45 пен 59 жас аралығында болды. MoСa ішкі шкалалары-визуалды-кеңістіктік және атқарушы функциялар, сағат және бағдар-бақылаумен салыстырғанда негізгі топта төмен болды (p<0,05). Бақылау тобында МоСА және Дене салмағының индексі көрсеткіші (r=0,39; p=0,015),...

29 June 2023 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
KSK.A. Shinalieva
K.A. Shinalieva
AKA.S. Kasenova
A.S. Kasenova
RKR.A. Karamullina
R.A. Karamullina
MPMikhail Poluektov
Mikhail Poluektov
IPI.V. Poluboyarinova
I.V. Poluboyarinova
GTG.S. Tazabekova
G.S. Tazabekova
Sleep disorders are very common in patients with type 2 diabetes (T2DM) and psychiatric disorders. Sleep disturbances can be both an independent condition and are one of the symptoms in the structure of a psychopathological syndrome. The negative impact of sleep disorders and mental disorders on the course of T2DM is known from numerous publications. This article presents current information on the mutual influence of mental disorders and sleep disorders on the course and prognosis of T2DM.

25 February 2022 in Vestnik
Verified
Journal Article
Closed access
ТБТ.т. Бокебаев
Т.т. Бокебаев
АКА.с. Касенова
А.с. Касенова
ГТГ.с. Тазабекова
Г.с. Тазабекова
Т.Т. Бокебаев, А.С. Касенова, Г.С. Тазабекова ВЛИЯНИЕ КОГНИТИВНЫХ НАРУШЕНИЙ НА КАЧЕСТВО СНА У ЛИЦ МОЛОДОГО ВОЗРАСТА...

17 June 2026 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
GKGaziz Kyrgyzbay
Gaziz Kyrgyzbay
AKAsemgul Kasenova
Asemgul Kasenova
RORaffaele Ornello
Raffaele Ornello
DADinara Alzhanova
Dinara Alzhanova
ZUZhassulan Utebekov
Zhassulan Utebekov
RARuslan Akhmedullin
Ruslan Akhmedullin
Prior research has revealed that chronic migraine is among the most commonly reported coexisting conditions in people with functional seizures (FS). We questioned whether migraine treatment affects FS frequency in these patients. We selected patients with chronic migraine and FS. Patients received no treatment in the initial 3 months (observation period), followed by two injections of botulinumtoxin type A (BT-A) in the fourth and seventh months, and were followed up for six months in the treatment period. Patient records on headache days and FS counts were analyzed using multilevel Poisson regression. The authors also conducted a mediation analysis. Overall, 30 patients completed 9 months follow-up period. The median age of the participants was 29 years (IQR: 24-37 years), with a female predominance (93.3%). The number of headache days and FS counts decreased with treatment 48.52% (95% CI: 41.68% to 54.55%) and 80.61% (69.51%-87.67%), respectively. Regression analyses revealed that treatment reduced the number of headache days by 8.58 (95% CI, 6.97-10.2, p < 0.001) and FS counts by 3.58 (95% CI, 2.33-4.83, p < 0.001) relative to the observation period. A within-participant mediation analysis revealed an indirect treatment effect on FS (2.62, 95% CI: 0.74-4.57). Migraine treatment may decrease FS counts in patients with FS. Further research is needed to assess the causal relationship between migraine attacks and FS. If confirmed in future studies, our findings underscore the importance of migraine screening and treatment in patients with FS.

20 April 2026 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
GKGaziz Kyrgyzbay
Gaziz Kyrgyzbay
DKDina Kalinina
Dina Kalinina
GZGuldana Zhumabayeva
Guldana Zhumabayeva
AKAsemgul Kasenova
Asemgul Kasenova
DADinara Alzhanova
Dinara Alzhanova
ZUZhassulan Utebekov
Zhassulan Utebekov
This exploratory study aims to explore whether a calm and safe environment, minimal external stimuli, and neutral behavior of bystanders and medical personnel may contribute to shorter functional seizure (FS) duration. This exploratory study included adults with documented-FS first diagnosed between December 2024 and August 2025. During seizures, only observation or minimal intervention to prevent harm was performed; no external stimuli (e.g., physical contact, manipulations, or forced head or body turning) were applied. Demographic and seizure-related data, healthcare utilization in the three months before diagnosis, and prospective 3-month follow-up data on seizure occurrence, duration, Emergency Medical Services (EMS) calls, and hospitalizations were collected. Twenty-one patients with documented-FS were included. Hypermotor seizures were the most frequent subtype, observed in 12 patients (57%). Headache, often migraine, was reported as a common trigger for seizures by 67%. The most frequently reported actions prior EMU were turning the patient onto their side (to presumably protect the airway), which was done in 18 patients (85.7%), and massaging or shaking the limbs/body to "stimulate" the patient, reported in 17 patients (81%), splash water (11 patients, 52.4%), restraining the patient's movements occurred in 10 patients (47.6%).The median reported duration of a typical seizure was 20 min (IQR 11.5-40 min) decreased to approximately 7 min (IQR 4-10 min), and to 8 min (IQR 5-10 min) post-Epilepsy Monitoring Unit (EMU) period. Patients frequently contacted EMS in response to their seizures, with a median of 11 calls (IQR 8-24), EMS calls by relatives (familiar with the diagnosis) dropped to 0 (IQR 0-1). In this exploratory study, FS recorded under calm, non-intervening conditions in the EMU were consistently shorter than patients' habitual seizures, and diagnosis combined with structured counseling was associated with marked reductions in emergency service use and hospitalizations.